TheraFlu LAR virus and sore throat spray, 30ml

Product description

Thera Flu LAR SPRAY is just 5 actions for sore throat*: antiseptic, local anesthetic, antibacterial (Gram ( + ), Gram ( – )), antiviral, antifungal. * Instructions for medical use, RU LS-001853 from 05.08.2011

Composition

>

1 ml contains:

Active ingredients:

benzoxonium chloride 2 mg,

lidocaine hydrochloride 1.5 mg;

Auxiliary substances:  

ethanol,

peppermint oil,

menthol,

glycerol,

hydrochloric acid,

purified water.

Pharmacological action

Thera Flu LAR has an antiseptic, anti-inflammatory effect.

Pharmacodynamics

Benzoxonium chloride is a quaternary ammonium salt: N-benzyl-N-dodecyl N, N-di (2-hydroxyethyl) ammonium chloride. Due to its cationic structure, it has membranotropic activity and has a pronounced antibacterial effect on gram-positive and, to a lesser extent, gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses).

Lidocaine is a local anesthetic that reduces pain in the throat when swallowing during inflammatory processes.

Pharmacokinetics

Benzoxonium chloride is practically not absorbed. Approximately 1% of the applied dose is detected in the urine, the concentration of the substance in the blood is practically not detected. No accumulation of the substance in the body’s tissues was detected.

Lidocaine is absorbed by oral use and through the oral mucosa. It is metabolized at the first pass through the liver, with an oral bioavailability of approximately 35%. Metabolites are excreted together with the urine, less than 10% of the substance is excreted unchanged.

Indications

Infectious and inflammatory diseases of the oral cavity and pharynx:

• stomatitis;
• pharyngitis;
• ulcerative gingivitis;
• catarrhal sore throat;
• laryngitis;
• chronic tonsillitis (as an auxiliary agent).

Use during pregnancy and lactation

The drug is contraindicated for use in the first trimester of pregnancy and during lactation (breastfeeding).

Adequate and strictly controlled clinical studies on the safety of the drug during pregnancy have not been conducted. The use of the drug in the second and third trimesters is not recommended.

There are no clinical data on the excretion of active substances in breast milk. However, the drug is not recommended for use during breastfeeding.

In experimental studies, no effect of the drug on the reproductive function and development of the fetus was found.

Contraindicated: children under 4 years of age.

Contraindications

Hypersensitivity to lidocaine or ammonia compounds.

Side effects

Local irritation may develop; if applied for more than 2 weeks, reversible brown coloration of the tongue and teeth.

How to take, course of use and dosage

Thera Flu LAR is applied topically.

Spray solution: spray into the mouth, holding the can vertically.

Adults — 4 sprays (approximately 0.5 ml) 3-6 times a day.

Children aged 4 years and older — 1 to 2-3 sprays 3-6 times a day.

Duration of treatment-no more than 5 days.

If there is no relief of symptoms within 5 days of therapy, the patient should consult a doctor.

Special instructions

During the use of Thera Flu LAR, alcohol consumption should be avoided.

Form of production

Spray

Storage conditions

At a temperature not exceeding 30 °C

Shelf life

5 years

Active ingredient

Benzalkonium Chloride, Lidocaine

Dosage Form

Oral spray